Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Chirag Desai & Bala Prabhakar. (2015) Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes. Drug Development and Industrial Pharmacy 41:10, pages 1589-1607.
Read now
Read now
Articles from other publishers (38)
Xammy Nguyenla, Eddie Wehri, Erik Van Dis, Scott B. Biering, Livia H. Yamashiro, Chi Zhu, Julien Stroumza, Claire Dugast-Darzacq, Thomas G. W. Graham, Xuanting Wang, Steffen Jockusch, Chuanjuan Tao, Minchen Chien, Wei Xie, Dinshaw J. Patel, Cindy Meyer, Aitor Garzia, Thomas Tuschl, James J. Russo, Jingyue Ju, Anders M. Näär, Sarah Stanley & Julia Schaletzky. (2022) Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells. Scientific Reports 12:1.
Crossref
Crossref
Seif El Hadidi, Giuseppe Rosano, Juan Tamargo, Stefan Agewall, Heinz Drexel, Juan Carlos Kaski, Alexander Niessner, Basil S Lewis, Andrew J S Coats & Gianluigi Savarese. (2022) Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing. European Heart Journal - Cardiovascular Pharmacotherapy 8:2, pages 187-210.
Crossref
Crossref
Mahmoud A. Saleh, Manar M. Taha, Mona A. Mohamed & Nageh K. Allam. (2021) A novel and ultrasensitive electrochemical biosensor based on MnO2-V2O5 nanorods for the detection of the antiplatelet prodrug agent Cilostazol in pharmaceutical formulations. Microchemical Journal 164, pages 105946.
Crossref
Crossref
Rania A. Elrashidy & Rehab A. Hasan. (2021) Cilostazol preconditioning alleviates cyclophosphamide-induced cardiotoxicity in male rats: Mechanistic insights into SIRT1 signaling pathway. Life Sciences 266, pages 118822.
Crossref
Crossref
Salvatore Santo Signorelli, Luca Vanella, Nader G. Abraham, Salvatore Scuto, Elisa Marino & Petra Rocic. (2020) Pathophysiology of chronic peripheral ischemia: new perspectives. Therapeutic Advances in Chronic Disease 11, pages 204062231989446.
Crossref
Crossref
Helmy Moawad, Sally A. El Awdan, Nada A. Sallam, Wafaa I El-Eraky & Mohammed A. Alkhawlani. (2019) Gastroprotective effect of cilostazol against ethanol- and pylorus ligation–induced gastric lesions in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 392:12, pages 1605-1616.
Crossref
Crossref
Wataru Asano, Yu Takahashi, Motoaki Kawano & Yoshiji Hantani. (2019) Identification of an Arginase II Inhibitor via RapidFire Mass Spectrometry Combined with Hydrophilic Interaction Chromatography. SLAS Discovery 24:4, pages 457-465.
Crossref
Crossref
Rong-wu Xiang, Ruo-bing Han, Jing-yu Yang, Ming-yi Zhao, Qing-chun Zhao, Hui-sheng Chen, Fang-qing Zhao, Zhong-yi Sun, Tong Zhao & Ting-yan Song. (2019) Comparative efficacy and safety of multiple antiplatelet therapies for secondary prevention of ischemic stroke or transient ischemic attack: A network meta-analysis. Journal of the Neurological Sciences 399, pages 199-206.
Crossref
Crossref
Nuccia Morici, Marisa Varrenti, Dario Brunelli, Enrico Perna, Manlio Cipriani, Enrico Ammirati, Maria Frigerio, Marco Cattaneo & Fabrizio Oliva. (2018) Antithrombotic therapy in ventricular assist device (VAD) management: From ancient beliefs to updated evidence. A narrative review. IJC Heart & Vasculature 20, pages 20-26.
Crossref
Crossref
Chakradhari Inampudi, Emmanuel Akintoye, Tomo Ando & Alexandros Briasoulis. (2018) Angiogenesis in peripheral arterial disease. Current Opinion in Pharmacology 39, pages 60-67.
Crossref
Crossref
Debbie Falconer, Nikolaos Papageorgiou, Karim Salem, Wei Yao Lim, Athanasios Katsargyris, Efthimios Avgerinos & Dimitris Tousoulis. (2018) Nitric oxide donors for peripheral artery disease. Current Opinion in Pharmacology 39, pages 77-85.
Crossref
Crossref
Lorenzo Valerio, Jawaad Sheriff, Phat L. Tran, William Brengle, Alberto Redaelli, Gianfranco B. Fiore, Federico Pappalardo, Danny Bluestein & Marvin J. Slepian. (2018) Routine clinical anti-platelet agents have limited efficacy in modulating hypershear-mediated platelet activation associated with mechanical circulatory support. Thrombosis Research 163, pages 162-171.
Crossref
Crossref
Yun Seob JungDongwoo ChaeKyungsoo Park. (2018) Population pharmacodynamics of cilostazol in healthy Korean subjects. Translational and Clinical Pharmacology 26:2, pages 93.
Crossref
Crossref
Alok B. Bhatt & James F. Benenati. 2018. IR Playbook. IR Playbook
331
340
.
Shu-Yu Tai, Chen-Yu Chien, Yu-Han Chang & Yuan-Han Yang. (2017) Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study. Neurotherapeutics 14:3, pages 784-791.
Crossref
Crossref
Jun-ichi Suzuki, Munehisa Shimamura, Hiroyuki Suda, Kouji Wakayama, Hidetoshi Kumagai, Yuichi Ikeda, Hiroshi Akazawa, Mitsuaki Isobe, Issei Komuro & Ryuichi Morishita. (2015) Current therapies and investigational drugs for peripheral arterial disease. Hypertension Research 39:4, pages 183-191.
Crossref
Crossref
Peng-Peng Niu, Zhen-Ni Guo, Hang Jin, Ying-Qi Xing & Yi Yang. (2016) Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis. BMJ Open 6:3, pages e009013.
Crossref
Crossref
Yu-Wen Li, Matthew A. Seager, Trevor Wojcik, Karen Heman, Thaddeus F. Molski, Alda Fernandes, Shaun Langdon, Annapurna Pendri, Samuel Gerritz, Yuan Tian, Yang Hong, Lizbeth Gallagher, James R. Merritt, Chongwu Zhang, Ryan Westphal, Robert Zaczek, John E. Macor, Joanne J. Bronson & Nicholas J. Lodge. (2016) Biochemical and behavioral effects of PDE10A inhibitors: Relationship to target site occupancy. Neuropharmacology 102, pages 121-135.
Crossref
Crossref
Shigeru Fujimoto, Masato Osaki, Makoto Kanazawa, Naoki Tagawa, Masaya Kumamoto, Yuichiro Ohya & Takanari Kitazono. (2016) Effect of oral cilostazol on acute neurological deterioration and outcome of noncardioembolic minor stroke. Journal of Clinical Gerontology and Geriatrics 7:1, pages 21-26.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
348
349
.
J.R. Exequiel T. Pineda, Esther S.H. Kim & Olusegun O. Osinbowale. (2015) Impact of Pharmacologic Interventions on Peripheral Artery Disease. Progress in Cardiovascular Diseases 57:5, pages 510-520.
Crossref
Crossref
Chirag Desai & Bala Prabhakar. (2014) Nano-amorphous composites of cilostazol–HP-β-CD inclusion complexes: physicochemical characterization, structure elucidation, thermodynamic studies and in vitro evaluation. Journal of Inclusion Phenomena and Macrocyclic Chemistry 81:1-2, pages 175-191.
Crossref
Crossref
F Ahmad, T Murata, K Shimizu, E Degerman, D Maurice & V Manganiello. (2014) Cyclic Nucleotide Phosphodiesterases: important signaling modulators and therapeutic targets. Oral Diseases 21:1.
Crossref
Crossref
Tariq Salman, Conner O’Keefe & Robert S. Dieter. 2015. PanVascular Medicine. PanVascular Medicine
2983
3006
.
GAOPING LIN, DONGDONG REN, SHUNYUAN GUO & YU GENG. (2014) Effectiveness of cilostazol in transient ischemic attack refractory to aspirin: A report of two cases. Experimental and Therapeutic Medicine 7:3, pages 739-741.
Crossref
Crossref
Yuji Aoki, Mika Shimizu & Nobuaki Watanabe. (2014) The Blood Glucose Level Increased in Parallel with the Heart Rate Following Cilostazol Administration in Three Diabetic Patients. Internal Medicine 53:8, pages 859-863.
Crossref
Crossref
Eduardo Fuentes, Lina Badimon, Julio Caballero, Teresa Padró, Gemma Vilahur, Marcelo Alarcón, Pablo Pérez & Iván Palomo. (2017) Protective mechanisms of adenosine 5′-monophosphate in platelet activation and thrombus formation. Thrombosis and Haemostasis 111:03, pages 491-507.
Crossref
Crossref
Robert S Dieter, Tariq Salman & Conner O’Keefe. 2013. PanVascular Medicine. PanVascular Medicine
1
26
.
Nicole L. Lohr, James T. Ninomiya, David C. Warltier & Dorothée Weihrauch. (2013) Far red/near infrared light treatment promotes femoral artery collateralization in the ischemic hindlimb. Journal of Molecular and Cellular Cardiology 62, pages 36-42.
Crossref
Crossref
Oluwaranti Akiyode, Tracy Thomas, Salome Weaver & Sarah Sahraoui. (2013) Peripheral Arterial Disease. Topics in Geriatric Rehabilitation 29:3, pages 179-186.
Crossref
Crossref
Nicholas J. Leeper, Anna Bauer-Mehren, Srinivasan V. Iyer, Paea LePendu, Cliff Olson & Nigam H. Shah. (2013) Practice-Based Evidence: Profiling the Safety of Cilostazol by Text-Mining of Clinical Notes. PLoS ONE 8:5, pages e63499.
Crossref
Crossref
Kazuhiro SASE. (2013) Regulatory science for antiplatelet therapies. Japanese Journal of Thrombosis and Hemostasis 24:3, pages 269-281.
Crossref
Crossref
Farzana Nawaz Ali & Teresa L. Carman. (2012) Medical Management for Chronic Atherosclerotic Peripheral Arterial Disease. Drugs 72:16, pages 2073-2085.
Crossref
Crossref
Craig R. Narins, Jason D. Pacos & Theodore I. Hirokawa. 2012. Manual of Outpatient Cardiology. Manual of Outpatient Cardiology
325
346
.
A. Rodríguez-Morata, C. Esteban-Gracia, A. Fernández-Heredero, R. Riera-Vázquez, F. Vaquero-Lorenzo & J.R. March-García. (2011) Farmacoterapia en el paciente con claudicación intermitente. Angiología 63:3, pages 113-118.
Crossref
Crossref
Randall W. FranzTammy GarwickKatie Haldeman. (2010) Initial Results of a 12-week, Institution-based, Supervised Exercise Rehabilitation Program for the Management of Peripheral Arterial Disease. Vascular 18:6, pages 325-335.
Crossref
Crossref
Yukito Shinohara, Yasuo Katayama, Shinichiro Uchiyama, Takenori Yamaguchi, Shunnosuke Handa, Kempei Matsuoka, Yasuo Ohashi, Norio Tanahashi, Hiroko Yamamoto, Chokoh Genka, Yasuhisa Kitagawa, Hideo Kusuoka, Katsuya Nishimaru, Motoo Tsushima, Yukihiro Koretsune, Tohru Sawada & Chikuma Hamada. (2010) Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. The Lancet Neurology 9:10, pages 959-968.
Crossref
Crossref
R. Verhaeghe & P. Verhamme. 2010. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions
371
374
.